Moors & Cabot Inc. acquired a new position in Cerner Co. (NASDAQ:CERN) in the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 3,100 shares of the company’s stock, valued at approximately $221,000.
A number of other large investors have also modified their holdings of the stock. Vanguard Group Inc. boosted its holdings in Cerner by 3.1% in the second quarter. Vanguard Group Inc. now owns 29,296,545 shares of the company’s stock worth $1,947,341,000 after purchasing an additional 876,919 shares in the last quarter. BlackRock Inc. boosted its holdings in Cerner by 0.8% during the second quarter. BlackRock Inc. now owns 18,436,042 shares of the company’s stock valued at $1,225,441,000 after acquiring an additional 137,320 shares during the period. FMR LLC boosted its holdings in Cerner by 0.8% during the second quarter. FMR LLC now owns 5,652,931 shares of the company’s stock valued at $375,750,000 after acquiring an additional 43,521 shares during the period. Capital International Investors boosted its holdings in Cerner by 0.3% during the third quarter. Capital International Investors now owns 4,851,296 shares of the company’s stock valued at $345,994,000 after acquiring an additional 12,178 shares during the period. Finally, American Century Companies Inc. boosted its holdings in Cerner by 62.4% during the second quarter. American Century Companies Inc. now owns 3,929,394 shares of the company’s stock valued at $261,187,000 after acquiring an additional 1,510,288 shares during the period. Hedge funds and other institutional investors own 82.06% of the company’s stock.
In related news, President Zane M. Burke sold 50,000 shares of the stock in a transaction dated Wednesday, December 13th. The shares were sold at an average price of $70.00, for a total value of $3,500,000.00. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Chairman Clifford W. Illig sold 4,000 shares of the stock in a transaction dated Tuesday, November 7th. The shares were sold at an average price of $65.96, for a total transaction of $263,840.00. Following the completion of the sale, the chairman now owns 1,229,719 shares of the company’s stock, valued at approximately $81,112,265.24. The disclosure for this sale can be found here. In the last quarter, insiders sold 788,000 shares of company stock valued at $52,190,800. 13.11% of the stock is owned by corporate insiders.
Cerner (NASDAQ:CERN) last released its earnings results on Thursday, October 26th. The company reported $0.61 earnings per share for the quarter, missing the Thomson Reuters’ consensus estimate of $0.62 by ($0.01). Cerner had a net margin of 13.37% and a return on equity of 18.03%. The company had revenue of $1.28 billion during the quarter, compared to the consensus estimate of $1.29 billion. During the same quarter in the previous year, the business posted $0.59 EPS. The firm’s quarterly revenue was up 7.7% on a year-over-year basis. research analysts forecast that Cerner Co. will post 2.25 EPS for the current year.
A number of equities research analysts have issued reports on CERN shares. Cantor Fitzgerald restated a “buy” rating and set a $77.00 price target on shares of Cerner in a report on Tuesday, October 10th. KeyCorp restated a “buy” rating and set a $76.00 price target on shares of Cerner in a report on Friday, September 22nd. Robert W. Baird restated a “hold” rating and set a $67.00 price target on shares of Cerner in a report on Thursday, August 31st. SunTrust Banks restated a “buy” rating and set a $79.00 price target on shares of Cerner in a report on Thursday, October 19th. Finally, Zacks Investment Research cut shares of Cerner from a “hold” rating to a “sell” rating in a report on Tuesday, September 26th. One analyst has rated the stock with a sell rating, fourteen have assigned a hold rating and nine have given a buy rating to the company. The stock presently has a consensus rating of “Hold” and an average price target of $69.50.
Cerner Company Profile
Cerner Corporation (Cerner) is a supplier of healthcare information technology (HCIT). The Company offers a range of intelligent solutions and services that support the clinical, financial and operational needs of organizations of all sizes. The Company’s segments include Domestic and Global. The Domestic segment includes revenue contributions and expenditures associated with business activity in the United States.
Want to see what other hedge funds are holding CERN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cerner Co. (NASDAQ:CERN).
Receive News & Ratings for Cerner Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cerner and related companies with MarketBeat.com's FREE daily email newsletter.